Type-D personality and depressive symptoms predict anxiety 12 months post-percutaneous coronary intervention

Journal of Affective Disorders

Volumn 103, Issue 1-3, 2007, Pages 197-203

  van Gestel, Yvette R B M ^a   Pedersen, Susanne S ^a,b   van de Sande, Meike ^a   de Jaegere, Peter P T ^a   Serruys, Patrick W ^a   Erdman, Ruud A M ^a   van Domburg, Ron T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

Author keywords

Anxiety; Coronary artery disease; Depression; PCI; Type D personality

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; FEMALE; HEART INFARCTION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERSONALITY DISORDER; PRIORITY JOURNAL; SMOKING HABIT; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANXIETY; CHARACTER; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PERSONALITY INVENTORY; RISK FACTORS; SOCIAL ADJUSTMENT;

EID: 34648851353     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.01.030     Document Type: Article

References (28)

1. Astin F., Jones K., and Thompson D.R. Prevalence and patterns of anxiety and depression in patients undergoing elective percutaneous transluminal coronary angioplasty. Heart Lung 34 6 (2005) 393-401
2. Bjelland I., Dahl A.A., Haug T.T., and Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J. Psychosom. Res. 52 2 (2002) 69-77
3. Carney R.M., and Freedland K.E. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol. Psychiatry 54 3 (2003) 241-247
4. Clark D.A., Cook A., and Snow D. Depressive symptom differences in hospitalized, medically ill, depressed psychiatric inpatients and nonmedical controls. J. Abnorm. Psychology 107 1 (1998) 38-48
5. Denollet J. Type D personality. A potential risk factor refined. J. Psychosom. Res. 49 4 (2000) 255-266
6. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom. Med. 67 1 (2005) 89-97
7. Denollet J., Sys S.U., Stroobant N., Rombouts H., Gillebert T.C., and Brutsaert D.L. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 347 8999 (1996) 417-421
8. Denollet J., Vaes J., and Brutsaert D.L. Inadequate response to treatment in coronary heart disease: adverse effects of type-D personality and younger age on 5-year prognosis and quality of life. Circulation 102 6 (2000) 630-635
9. Denollet J., Pedersen S.S., Ong A.T., Erdman R.A., Serruys P.W., and van Domburg R.T. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era. Eur. Heart J. 27 2 (2006) 171-177
10. Eaker E.D., Sullivan L.M., Kelly-Hayes M., D'Agostino Sr. R.B., and Benjamin E.J. Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study. Psychosom. Med. 67 5 (2005) 692-696
11. Grace S.L., Abbey S.E., Irvine J., Shnek Z.M., and Stewart D.E. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother. Psychosom. 73 6 (2004) 344-352
12. Haworth J.E., Moniz-Cook E., Clark A.L., Wang M., Waddington R., and Cleland J.G. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur. J. Heart Fail. 7 5 (2005) 803-808
13. Januzzi Jr. J.L., Stern T.A., Pasternak R.C., and DeSanctis R.W. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch. Intern. Med. 160 13 (2000) 1913-1921
14. Krumholz H.M., Peterson E.D., Ayanian J.Z., Chin M.H., DeBusk R.F., Goldman L., Kiefe C.I., Powe N.R., Rumsfeld J.S., Spertus J.A., and Weintraub W.S. Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation 111 23 (2005) 3158-3166
15. Lane D., Carroll D., Ring C., Beevers D.G., and Lip G.Y. The prevalence and persistence of depression and anxiety following myocardial infarction. Br. J. Health Psychol. 7 Pt 1 (2002) 11-21
16. Lett H.S., Blumenthal J.A., Babyak M.A., Sherwood A., Strauman T., Robins C., and Newman M.F. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom. Med. 66 3 (2004) 305-315
17. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry 55 7 (1998) 580-592
18. Nicholson A., Fuhrer R., and Marmot M. Psychological distress as a predictor of CHD events in men: the effect of persistence and components of risk. Psychosom. Med. 67 4 (2005) 522-530
19. Pedersen S.S., and Denollet J. Type D personality, cardiac events, and impaired quality of life: a review. Eur. J. Cardiovasc. Prev. Rehabil. 10 4 (2003) 241-248
20. Pedersen S.S., and Denollet J. Is Type D Personality here to stay? Emerging evidence across cardiovascular disease patient groups. Curr. Cardiol. Rev. 2 (2006) 205-213
21. Pedersen S.S., Lemos P.A., van Vooren P.R., Liu T.K., Daemen J., Erdman R.A., Smits P.C., Serruys P.W., and van Domburg R.T. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy. J. Am. Coll. Cardiol. 44 5 (2004) 997-1001
22. Pedersen S.S., van Domburg R.T., Theuns D.A., Jordaens L., and Erdman R.A. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom. Med. 66 5 (2004) 714-719
23. Pedersen S.S., Denollet J., Spindler H., Ong A.T., Serruys P.W., Erdman R.A., and van Domburg R.T. Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention. J. Psychosom. Res. 61 6 (2006) 783-789
24. Pedersen S.S., Ong A.T., Sonnenschein K., Serruys P.W., Erdman R.A., and van Domburg R.T. Type D personality and diabetes predict the onset of depressive symptoms in patients after percutaneous coronary intervention. Am. Heart J. 151 2 (2006) 367 e1-367 e6
25. Spindler H., Pedersen S.S., Serruys P.W., Erdman R.A., and van Domburg R.T. Type-D personality predicts chronic anxiety following percutaneous coronary intervention in the drug-eluting stent era. J. Affect. Disord. 61 6 (2006) 783-789
26. Strik J.J., Denollet J., Lousberg R., and Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J. Am. Coll. Cardiol. 42 10 (2003) 1801-1807
27. van Melle J.P., de Jonge P., Spijkerman T.A., Tijssen J.G., Ormel J., van Veldhuisen D.J., van den Brink R.H., and van den Berg M.P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom. Med. 66 6 (2004) 814-822
28. Zigmond A.S., and Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67 6 (1983) 361-370